Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M. Carrasco Perez
Pdb73 - Indirect Cost-Effectiveness Analysis of Empagliflozin Compared to Canagliflozin for Patients With T2dm and Cardiovascular Disease in the Spanish National Health Service
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Pdb71 - Assessing the Relative Cost-Effectiveness of Empagliflozin and Canagliflozin for the Treatment of Type 2 Diabetes Patients With Existing Cardiovascular Disease in the Uk
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pcv74 - Cost-Effectiveness Analysis of Rosuvastatin Compared to Atorvastatin in Spanish Patients at Moderate, High, and Very High Cardiovascular Risk
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost-Effectiveness of Varenicline Compared to Placebo as an Aid to Smoking Cessation in Patients With Cardiovascular Disease
The Open Pharmacoeconomics & Health Economics Journal
Pdb76 - Cost-Effectiveness Analysis of Empagliflozin in Comparison to Liraglutide Based on Cardiovascular Outcome Trials
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Ce1 - Cost-Effectiveness Analysis of Empagliflozin in Comparison to Sitagliptin and Saxagliptin Based on Cardiovascular Outcome Trials
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pcv51 - Cost Analysis of Safety Outcomes of Dabigatran vs. Warfarin in the Spanish National Health Service
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pdb54 - Estimated Events Avoided and Cost Offsets Associated With Using Canagliflozin to Treat Patients With Type Two Diabetes Mellitus (T2dm) With or at High Risk of Developing Cardiovascular Disease (Cvd) in England
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost-Effectiveness Analysis of Atorvastatin Compared to Simvastatin in the Prevention of Cardiovascular Diseases in the Czech Republic
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost of the National Health Service
The Lancet
Medicine
